臺灣核心實作指引(TW Core IG), published by 衛生福利部. This guide is not an authorized publication; it is the continuous build for version 0.3.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cctwFHIRterm/MOHW_TWCoreIG_Build/ and changes regularly. See the Directory of published versions
用藥聲明的狀態:Active ( Medication Status Codes#active)
用藥聲明的分類: Outpatient ( MedicationDispense Category Codes#outpatient)
藥品:爽胰達注射劑100單位+50微克(ASPIRIN TABLETS 500MG S.Y.) ( 臺灣食藥署藥品許可證#衛部菌疫輸字第001080號)
病人:Patient/pat-example "陳加玲"
用藥的日期與時間:2023-11-05T08:00:00
提出聲明日期與時間:2023-11-05T10:00:00
聲明原因:第一型糖尿病(Type 1 diabetes mellitus) ( SNOMED CT#46635009)
藥品使用方式:
使用時間:每日使用1次
方式:皮下注射(SC use) ( SNOMED CT#34206005)
備註:每日注射一次,於餐前一小時內注射,建議固定在同一餐的餐前注射。